Features | Partner Sites | Information | LinkXpress
Sign In
JIB
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING

Scientists Unravel Antibacterial Mechanisms of Plasma Components

By BiotechDaily International staff writers
Posted on 10 Oct 2013
Image: Plasma Reactor – cold atmospheric-pressure plasmas are generated and tested for effects on bacterial cells and molecules (Photo courtesy of Jan-Wilm Lackmann, Ruhr University Bochum.)
Image: Plasma Reactor – cold atmospheric-pressure plasmas are generated and tested for effects on bacterial cells and molecules (Photo courtesy of Jan-Wilm Lackmann, Ruhr University Bochum.)
Scientists have unraveled the main mechanisms of the antibacterial action of cold atmospheric-pressure plasmas, further indicating their potential value as disinfection and antibiotic agents.

As they destroy bacteria very efficiently, atmospheric-pressure plasmas constitute an alternative to chemical disinfectants and are already being used as surgical tools, for example in nasal and intestinal polyp extraction. Their disinfectant properties may also be of interest for other applications, including wound treatment, cosmetic care, and in certain uses even as alternatives to antibiotics. “In ten years, bacteria might have developed resistance against all antibiotics that are available to us today,” said Junior Professor Dr. Julia Bandow, head of the Junior Research Group Microbial Antibiotic Research at Ruhr-Universität Bochum (Ruhr University Bochum (RUB); Bochum, Germany). Without antibiotics, most surgeries would become impossible due to high infection rates.

Cold atmospheric-pressure plasmas attack the prokaryote cell envelope, proteins, and DNA. “This is too great a challenge for the repair mechanisms and the stress response systems of bacteria,” said Prof. Bandow; “In order to develop plasmas for specific applications, for example for treating chronic wounds or for root canal disinfection, it is important to understand how they affect cells. Thus, undesirable side effects may be avoided right from the start.”

Effects of the plasma-emitted particles have now been investigated by a team of biologists, plasma physicists, and chemists at RUB. Depending on their specific composition, plasmas may contain different components, for example ions, radicals, or light in the ultraviolet spectrum—UV photons. Until now, scientists have had almost no understanding about which components of the complex mixture contribute to which extent to the antibacterial effect. Prof. Bandow’s team has analyzed the effect of reactive particles (radicals and ozone) and UV photons on both the cellular level and on the level of single biomolecules, namely DNA and proteins. On the cellular level, the reactive particles alone were most effective: they destroyed the cell envelope (UV radiation did not). On the molecular level, both plasma components were effective: both UV radiation and reactive particles damaged the DNA; in addition, the reactive particles inactivated proteins. Thus, damage to the cellular envelope as well as to DNA and proteins contribute to the bactericidal properties of cold atmospheric-pressure plasma.

The study was published September 25, 2013, in the Journal of the Royal Society Interface.

Related Links:

Ruhr University Bochum



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This micrograph depicts the presence of aerobic Gram-negative Neisseria meningitidis diplococcal bacteria; magnification 1150x (Photo courtesy of the CDC - US Centers for Disease Control and Prevention).

Infection by Meningitis Bacteria Depends on Dimerization State of Certain Host Cell Proteins

A team of molecular microbiologists has untangled the complex three-way interaction between the non-integrin laminin receptor (LAMR1), galectin-3 (Gal-2), and the pathogenic bacterium Neisseria meningitidis.... Read more

Drug Discovery

view channel

Molecule in Green Tea Used as Carrier for Anticancer Proteins

A molecule that is a key ingredient in green tea can be employed as a carrier for anticancer proteins, forming a stable and effective therapeutic nanocomplex. This new discovery could help to construct better drug-delivery systems. Some cancer treatments depend on medication comprising the therapeutic drug and a carrier... Read more

Business

view channel

Interest in Commercial Applications for Proteomics Continues to Grow

Increasing interest in the field of proteomics has led to a series of agreements between private proteomic companies and academic institutions as well as deals between pharmaceutical companies and novel proteomics innovator biotech companies. Proteomics is the study of the structure and function of proteins.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.